Cerepeut Study in Neuron Identifies Mitochondrial Mechanism Driving Tau-Related Neurodegeneration and Highlights CP-235 as Potential Therapy Cerepeut, Inc., a biotechnology company focused on developing mitochondrial therapeutics for neurodegenerative diseases, has announced the publication of new research in Neuron that identifies…
City of Hope Study Shows Education Program Can Dramatically Improve Skin Cancer Screening Among Hematopoietic Cell Transplant Survivors Experts at City of Hope®, one of the nation’s leading cancer research and treatment organizations, are highlighting the importance of skin cancer…
ZAP Surgical Expands Presence in China with New ZAP-X Radiosurgery Installation at Changchun Tumor Hospital ZAP Surgical Systems, Inc., a global innovator in non-invasive robotic brain surgery technologies, has announced the installation of its advanced ZAP-X® Gyroscopic Radiosurgery® platform at…
Niagen Bioscience Partners with Evotec to Advance NB4168 Development for Rare Genetic Disease Niagen Bioscience, Inc. (NASDAQ: NAGE), a biotechnology company recognized for its leadership in NAD+ (nicotinamide adenine dinucleotide) science and healthy aging research, has announced a strategic collaboration…
Seaport Therapeutics Reports Second Quarter 2026 Results, Highlights Positive Clinical Progress and Strengthened Financial Position Following IPO Seaport Therapeutics, Inc., a clinical-stage biotechnology company focused on developing innovative treatments for neuropsychiatric disorders, has announced its financial results for the second…
miRecule and Rio Biofarma Brasil Partner to Advance Next-Generation RNA Delivery Technologies miRecule, Inc., a biotechnology company focused on developing next-generation RNA therapeutics for rare genetic diseases, has entered into a strategic research collaboration with Rio Biofarma Brasil Ltda. (RBBL),…
Latigo Biotherapeutics Publishes Positive Phase 2 LTG-001 Acute Pain Trial Results in The New England Journal of Medicine Latigo Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing innovative non-opioid medicines for pain management, has announced the publication of positive…
Virta Health Study Suggests Nutrition-Based Metabolic Care May Significantly Reduce Risk of Chronic Kidney Disease Virta Health, a leader in reversing metabolic disease through individualized nutrition-based care, has announced the publication of a major peer-reviewed study demonstrating that chronic kidney…
Shionogi Launches XOCOVA® in the United States as the First Oral Post-Exposure COVID-19 Prevention Therapy Shionogi Inc., the U.S. subsidiary of Japan-based pharmaceutical company Shionogi & Co., Ltd., has announced the commercial availability of XOCOVA® (ensitrelvir) in the United States…
bioAffinity Technologies Publishes Clinical White Paper Highlighting Practical Use of CyPath® Lung for Pulmonary Nodule Risk Assessment bioAffinity Technologies, Inc., a biotechnology company dedicated to advancing noninvasive diagnostics and early cancer detection, has announced the publication of a comprehensive clinical…
Arcus Biosciences and Summit Therapeutics Collaborate to Advance Novel Combination Therapy for Advanced Kidney Cancer Arcus Biosciences, Inc., a clinical-stage global biopharmaceutical company focused on developing innovative therapies for cancer as well as inflammatory and autoimmune diseases, has entered into…
Kairos Pharma and Bayer Partner to Advance Combination Therapy for Metastatic Prostate Cancer Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company focused on developing therapies that overcome cancer drug resistance, has announced a strategic research collaboration with Bayer to evaluate its…